Valcárcel, D., Sanz, G., Ortega, M., Nomdedeu, B., Luño, E., Diez-Campelo, M., Ardanaz, M. T., Pedro, C., Montoro, J., Collado, R., Andreu, R., Marco, V., Cedena, M. T., de Paz, R., Tormo, M., Xicoy, B., Ramos, F., Bargay, J., Gonzalez, B., Brunet, S., Muñoz, J. A., Gomez, V., Bailén, A., Sanchez, J., Merchán, B., del Cañizo, C., Vallespí, T., & , (2015). use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study. Lancet, 2(6), e260–e266. http://access.bl.uk/ark:/81055/vdc_100066538962.0x000002